RecruitingObservational

Mayo Clinic Radiotherapy Patient Outcomes Registry and Biobanking Study

NCT ID: NCT02457962Sponsor: Mayo ClinicLast updated: 2026-04-01

Summary

To collect and analyze specimens that will correlate with clinical outcomes such as acute and late toxicities, quality of life, local control, and survival of patients treated with photon/proton therapy.

Outcome measures

Primary

analyze acute and late toxicities using CTCAE 4.03
Time frame: Patients will be followed for the duration of their life, an expected average of 20 years
analyze quality of life using LASA-3 and FACT-E
Time frame: Patients will be followed for the duration of their life, an expected average of 20 years

Secondary

analyze local control through tumor assessments
Time frame: Patients will be followed for the duration of their life, an expected average of 20 years
analyze survival by contacting patient and EMR (electronic medical record) review
Time frame: Patients will be followed for the duration of their life, an expected average of 20 years

Eligibility criteria

Sex: AllAge: All agesHealthy volunteers: No

Inclusion Criteria: 1. Treated with photon/proton at Mayo Clinic Rochester in Radiation Oncology 2. Radiation therapy for curative intent Exclusion Criteria: None

Study locations (1)

Mayo Clinic

Rochester, Minnesota, 55905

Recruiting

Clinical Trials Referral Office · Contact

855-776-0015

Nadia N. Laack, MD · Principal Investigator